
A potential long-term shift towards nationalized medicine in the US presents a significant risk to the for-profit healthcare sector. This bearish outlook suggests that companies like private health insurers, large hospital systems, and pharmaceutical firms could face major headwinds. While this is a thematic risk expected to play out over the next decade, it could gradually pressure stock valuations. Investors with heavy exposure to the US healthcare industry should review their holdings. Consider this potential long-term disruption as a key risk factor in your investment thesis for the sector.
Based on the transcript provided, there are no specific stocks or cryptocurrencies mentioned. However, the speaker discusses a major investment theme related to a significant sector of the economy.

By @theprofgpod
NYU Professor, best-selling author, business leader and serial entrepreneur Scott Galloway cuts through the biggest stories in ...